Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patients

Author： Mercadante Sebastiano   Adile Claudio   Torta Riccardo   Varetto Antonella   Fulfaro Fabio   Giarratano Antonino   Casuccio Alessandra  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.29, Iss.1, 2013-01, pp. : 93-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain

By  

EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol. 19, Iss. 7, 2015-08 ,pp. : 881-888

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of breakthrough cancer pain: to titrate or to proportionate?

By Hans Guy H.  

Current Medical Research and Opinion, Vol. 29, Iss. 11, 2013-11 ,pp. : 1523-1526

Informa Healthcare

Access to resources Recommend Favorite

Fentanyl for Breakthrough Cancer Pain: Where are We?

By  

Reviews on Recent Clinical Trials, Vol. 8, Iss. 1, 2013-03 ,pp. : 42-47

Bentham Science Publishers

Access to resources Recommend Favorite

Initial pharmacokinetic, safety and efficacy evaluation of nasal morphine gluconate for breakthrough pain in cancer patients

By Fitzgibbon D.   Morgan D.   Dockter D.   Barry C.   Kharasch E.D.  

Pain, Vol. 106, Iss. 3, 2003-12 ,pp. : 309-315

Elsevier

Access to resources Recommend Favorite

Sublingual fentanyl orally disintegrating tablet in daily practice: efficacy, safety and tolerability in patients with breakthrough cancer pain

By ÜÜberall Michael A.   Müüller-Schwefe Gerhard H.H.  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1385-1394

Informa Healthcare

Access to resources Recommend Favorite